Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Indaptus Therapeutics, Inc.

1.29
-0.0900-6.52%
Post-market: 1.300.0100+0.78%19:34 EDT
Volume:1.14M
Turnover:1.50M
Market Cap:171.57M
PE:-2.71
High:1.58
Open:1.39
Low:1.18
Close:1.38
52wk High:8.57
52wk Low:0.9200
Shares:133.00M
Float Shares:23.24M
Volume Ratio:0.42
T/O Rate:4.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4756
EPS(LYR):-21.5800
ROE:-318.04%
ROA:-98.08%
PB:15.09
PE(LYR):-0.06

Loading ...

OverviewCompanyNewsFilings

Indaptus Therapeutics files Form 3; Sino Lion Ventures reports beneficial ownership

Reuters
·
Apr 03

Indaptus Therapeutics files Form 3 for CEO Junyi Dai initial beneficial ownership statement

Reuters
·
Apr 03

Indaptus Therapeutics FY2025 annual report published; net loss widens to $21 million

Reuters
·
Mar 27

Indaptus investors group discloses 96.2% beneficial ownership after preferred conversion

Reuters
·
Mar 25

Indaptus Therapeutics FY2025 net loss widens 38.8% to USD 20.85 million

Reuters
·
Mar 18

Indaptus Therapeutics Inc expected to post a loss of $4.36 a share - Earnings Preview

Reuters
·
Mar 06

Indaptus Therapeutics Wins Approval for Reverse Stock Split Authority

Reuters
·
Feb 28

Indaptus Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Jerome D. Jabbour

Reuters
·
Feb 28

Indaptus Therapeutics Director Matthew Charles McMurdo Files Initial Statement of Beneficial Ownership (Form 3)

Reuters
·
Feb 26

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Aug 13, 2026 Pre-MKt
Financial Report Announcement
May 15, 2026 Pre-MKt
Financial Report Announcement
Mar 17, 2026 Post-Mkt
Financial Report Announcement
Nov 12, 2025 Pre-MKt
Financial Report Announcement
Aug 13, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.71
Current
-2.81
Sector Average
6.92%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.71
Maximum
-0.13
+1 STD
1.63
Minimum
-28.52
-1 STD
-7.25
Average
-2.81

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.